SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-------------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): October 9, 2000
---------------
CYTOGEN CORPORATION
-------------------
(Exact Name of Registrant as Specified in Charter)
Delaware 000-14879 222322400
---------------------------- ---------------- -------------------
(State or Other Jurisdiction (Commission File (I.R.S. Employer
of Incorporation) Number) Identification No.)
600 College Road East, CN5308
Princeton, NJ 08540
----------------------------- ----------
(Address of Principal (Zip Code)
Executive Offices)
Registrant's telephone number, including area code: (609) 750-8200
--------------
<PAGE>
ITEM 5. OTHER EVENTS.
On October 9, 2000, Cytogen Corporation, a Delaware corporation (the
"Company") entered into an Equity Financing Facility (the "Facility") under the
terms of a Common Stock Purchase Agreement (the "Agreement") with Acqua
Wellington North American Equities Fund, Ltd. ("Acqua Wellington"). Under the
terms of the Agreement, the Company may, at its sole discretion and from time to
time over the next 20 months, sell shares of its Common Stock to Acqua
Wellington at a small discount to market price, as determined prior to each such
sale. The Facility is not subject to any minimum takedown requirements and
provides for the sale of up to $70 million in registered shares of the Company's
Common Stock. A complete copy of the Agreement and related press release are
filed herewith as Exhibit 10.1 and Exhibit 99.1, respectively.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(a) Exhibits.
--------
Exhibit No. Description
----------- -----------
10.1 Common Stock Purchase Agreement
99.1 Press Release dated October 10, 2000
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this current report on Form 8-K to be signed on its
behalf by the undersigned hereunto duly authorized.
CYTOGEN CORPORATION
By: /s/ Catherine M. Verna, Esq.
----------------------------
Catherine M. Verna, Esq.
Vice President and General Counsel
Dated: October 12, 2000
<PAGE>
EXHIBIT INDEX
Exhibit No. Description
----------- -----------
10.1 Common Stock Purchase Agreement
99.1 Press Release dated October 10, 2000
